Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulation, 2018

Kothari Sugars And Chemicals Limited has informed the Exchange about the receipt of Order passed by the Honble National Company Law Tribunal, Chennai Bench, in connection with the proposed Scheme of Amalgamation directing the companies for convening the respective meetings of shareholders and unsecured creditors.

Kothari Sugars And Chemicals Limited has informed the Exchange about Copy of Newspaper Publication

Intimation under Regulation 30 (LODR) - Reappointment of Director, who retires by rotation, regularisation of Additional Independent Director as Independent Director, Re-appointment of Secretarial Auditor

We wish to inform the changes in the SMP of the Company, arising due to completion of contractual arrangements between the company and Mr. Sendhil Pani, Managing Director of Sudeep Pharma USA Inc., (Wholly Owned Subsidiary of Sudeep Pharma Limited) w.e.f. 2nd October 2026. Kindly take the note of the same.

Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. This is to inform you that the tenure of Ms. Nainna Guptaa has expired as the appointment of Ms. Nainna Guptaa could not be placed before the members of the Company for consideration and regularisation of her office due to non conduct of the Annual General Meeting.

Filatex Fashions Limited has informed the Exchange regarding Regularisation of Ms Smitaben Suthar as Non- Executive Independent Director of the company w.e.f. July 17, 2026.

Filatex Fashions Limited has informed the Exchange regarding Regularisation of Mr Pratik Bharatbhai Panchal as Non- Executive Independent Director of the company w.e.f. July 07, 2026.

Please find enclosed herewith combined report of voting of 16th annual General Meeting.

Please find enclosed herewith Combined Report (Scrutinizer Report and Outcome of Voting) of Voting for 16th Annual General Meeting.

Intimation of regularisation of appointment of additional director under regulation 30 of the SEBI (LODR) Regulation, 2015

Aristo Bio-Tech And Lifescience Limited has informed the Exchange regarding Re-Appointment of Ms. Rashmi Kamlesh Otavani as Non- Executive Independent Director of the company w.e.f. March 20, 2027.

Aristo Bio-Tech And Lifescience Limited has informed the Exchange regarding Appointment of Mr Ketankumar Harkantbhai Modi as whole Time Director of the company w.e.f. March 20, 2027.

Aristo Bio-Tech And Lifescience Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results.

Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, we wish to inform you that the Members of the Company at the 11th AGM, held on Tuesday, 29th September, 2026 have approved the regularisation of Mr. Mohit Paragbhai Bhavnagari (DIN: 10568605), Additional Director (Non-Executive Category), by appointing him as a Director (Non-Executive Category) of the Company.

Omaxe Limited has informed the Exchange about Sale of 40% Equity Shares of M/s Aquarise Developers Private Limited held by M/s Dinkar Realcon Private Limited (step down Wholly Owned Subsidiary of Omaxe Limited).

Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, we wish to inform you that the Members of the Company at the 11th AGM, held on Tuesday, 29th September, 2026 have approved the regularisation of Mr. Aditya Gaurangbhai Patel (DIN: 11878623), Additional Director (Non-Executive Category), by appointing him as a Director (Non-Executive Category) of the Company.

Please find enclosed herewith intimation w.r.t. Sale of 40% Equity Shares of M/s Aquarise Developers Private Limited held by M/s Dinkar Realcon Private Limited (Step Down Wholly Owned Subsidiary of Omaxe Limited).

Uniinfo Telecom Services Limited has informed the Exchange about appointment M/s. Harish Khandelwal & Co., Chartered Accountants (Firm Registration No. 004116C), as the Statutory Auditors of the Company.